老年基层医疗中中枢神经系统药物停用后的替代模式
该研究基于STOP-FALLS试验的二次分析,纳入2182名长期使用阿片类、苯二氮䓬类、三环类抗抑郁药、骨骼肌松弛剂或Z药物的老年患者,评估停用中枢神经系统药物后的替代情况。结果显示2415种目标药物中442种(18.3%)被停用,其中42例(9.5%)发生替代,替代药物中26.2%为2023年Beers标准中潜在不适当药物。
要点
- 中枢神经系统药物停用后约9.5%出现替代,其中约四分之一为潜在不适当药物。
- 骨骼肌松弛剂停用率最高(49.7%),阿片类最低(8.0%)。
- 常见替代药物包括加巴喷丁、SNRI及曲唑酮。
核心结论
- 中枢神经系统药物停用后发生的替代中,约四分之一为至少一种潜在不适当药物,提示需为处方者提供安全减药指导。
研究设计与样本
- STOP-FALLS减药试验的二次分析,合并干预组与常规照护组数据,随访基线后360天,纳入长期使用阿片类、苯二氮䓬类、三环类抗抑郁药、骨骼肌松弛剂或Z药物的参与者,共2182人(平均年龄70.5岁,女性63.1%)。
主要发现
- 基线共2415种目标药物,442种(18.3%)被停用,停用率从阿片类的122种(8.0%)到骨骼肌松弛剂的86种(49.7%)不等。
- 42例(9.5%)停用发生替代,其中11例(26.2%)替代为潜在不适当药物:三环类抗抑郁药5例、苯二氮䓬类3例、羟嗪3例。
- 其他常见替代药物包括加巴喷丁、选择性5-羟色胺去甲肾上腺素再摄取抑制剂(SNRI)和曲唑酮。
关键数值与推荐
- 潜在不适当药物依据2023年Beers标准判定。
- 停用定义为首次出现连续90天无处方配药记录,仅纳入前270天内发生停用者。
- 替代定义为停用目标药物前30天至后60天内新开替代药物。
临床怎么用
- 老年医学科医生在停用中枢神经系统药物时,应主动评估并避免以潜在不适当药物(如三环类抗抑郁药、苯二氮䓬类、羟嗪)作为替代。
- 对骨骼肌松弛剂等高停用率药物,减药后需加强随访,防止不适当替代。
局限性
- 本研究为二次分析,替代定义基于处方配药记录,可能未完全反映实际用药。
- 样本来自特定减药试验人群,结论外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Little is known about substitution of alternative medications in the context of deprescribing. The objectives were to: (1) determine the frequency of medication substitutions among those who discontinued a central nervous system (CNS)-active medication, and (2) characterize substitutions as potentially inappropriate (as per the 2023 Beers Criteria) versus not. METHODS: We conducted a secondary analysis that combined data from the intervention and usual care arms from the STOP-FALLS deprescribing trial that tested a health-system-embedded intervention designed to reduce prescription of CNS-active medications. This analysis focused on participants followed for 360 days following baseline with chronic use of opioids, benzodiazepines, tricyclic antidepressants, skeletal muscle relaxants, or Z-drugs. Discontinuation was defined as the first date when there was no evidence of a prescription fill for 90 days, thus only participants with a discontinuation that occurred in the first 270 days were included. A list of likely alternative treatments was developed for each target medication. A substitution was operationalized as a new alternative medication prescribed during the 30 days prior to or 60 days after discontinuation of a target medication. RESULTS: The study sample included 2182 individuals (average age 70.5 years, 63.1% female). At baseline, a total of 2415 target medications were prescribed, of which 442 (18.3%) were discontinued. Discontinuation rates varied from 122 (8.0%) for users of opioids to 86 (49.7%) for users of skeletal muscle relaxants. Substitutions were made for 42 (9.5%) drug discontinuations. Of these substitutions, 11 of 42 (26.2%) were to a potentially inappropriate medication: tricyclic antidepressants (n = 5), benzodiazepines (n = 3) and hydroxyzine (n = 3). Other common substitutions included gabapentin, selective serotonin norepinephrine reuptake inhibitors, and trazodone. DISCUSSION: Of medication discontinuations with a substitution, one-quarter were to at least one potentially inappropriate medication. This finding highlights the need for additional guidance for prescribers to ensure safe deprescribing of CNS-active medications.
引用
- Gray SL, Piccorelli AV, Hart LA, et al. Substitution Patterns After Discontinuation of CNS-Active Medications in Older Adults in Primary Care. J Am Geriatr Soc. 2026. PMID: 42281185. doi:10.1111/jgs.70514
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。